insights_auto
Why is NANO up 4.37%?
Dive Deeperchevron_right
NANO:EPA
Nanobiotix SA
€29.16
arrow_upward
+4.37%(+1.22) 1D
Sep 25, 5:35:26 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NANO...
Open
€29.04
High
€29.54
Low
€27.12
Mkt. cap
1.48B
Avg. vol.
154.84K
Volume
196.59K
52-wk high
€47.66
52-wk low
€11.80
EPS
-€0.50
Shares outstanding
50.62M
No. of employees
100
Open
€29.04
High
€29.54
Low
€27.12
Mkt. cap
1.48B
Avg. vol.
154.84K
Volume
196.59K
52-wk high
€47.66
52-wk low
€11.80
EPS
-€0.50
Shares outstanding
50.62M
No. of employees
100
News stories
From web sources and news partners
Idéal Investisseur
·
9 hours ago
Nanobiotix Results: €110.9M in Cash, Financing Expected Until 2029
TradingView
·
18 hours ago
Nanobiotix S.A. H1 Net Income EUR -34.3 Million
TipRanks
·
20 hours ago
Nanobiotix advances cancer nanotherapeutics and bolsters cash runway into 2029
Yahoo Finance UK
·
20 hours ago
NANOBIOTIX Provides First Half 2026 Operational and Financial Update
Profile
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
About Nanobiotix SA